
Edwards, a former partner at EY, will serve on Solventum’s Audit and Talent committees. Her appointment went into effect on April 12.
“We are excited to welcome Shirley to our board of directors,” Solventum CEO Bryan Hanson said in a news release. “Her extensive expertise in mergers and acquisitions, corporate governance, performance enhancement, finance and human resources will serve as a valuable resource as Solventum advances its specialized growth and market strategies, along with capital allocation approaches.”
Edwards’ track record includes 20 years spent at EY in significant leadership and client services roles. Her time at EY ended with five years spent as global client service partner from 2017 to 2022. She also handled the stewardship of EY’s nearly $4 billion assurance practice across 20 countries in the Americas.
“Shirley joins a robust board that brings deep expertise across healthcare, strategy and finance. We are ready to bring forward Solventum’s mission of enabling better, smarter, safer health care to improve lives,” said Carrie Cox, chair of the Solventum board of directors.
Edwards joins Hanson and Cox on the board. Current members also include:
- Susan D. DeVore, former CEO, Premier
- Glenn A. Eisenberg, EVP and CFO, Laboratory Corporation of America
- Dr. Bernard A. Harris Jr., former NASA astronaut, CEO and managing partner, Versalius Ventures
- Karen J. May, former EVP and chief human resources officer, Mondelez International
- Elizabeth A. Mily, former EVP, strategy & business development, Bristol-Myers Squibb
- John H. Weiland, former president and COO, C.R. Bard
- Amy A. Wendell former SVP, strategy and business development and licensing, Covidien
- Darryl L. Wilson, former VP, commercial, GE
- Carlos Albán, former vice chair and CCO, AbbVie, Inc.
Background on Solventum
Solventum became a standalone company on April 1, trading on the New York Stock Exchange under the “SOLV” ticker.
3M first announced plans to spin off its Health Care unit in June 2022. The St. Paul, Minnesota–based manufacturing giant named the standalone company, which generates more than $8 billion in annual revenue, “Solventum” in November 2023.
Solventum boasts more than 20,000 employees, led by former Zimmer Biomet CEO Bryan Hanson as CEO. The company also landed former Insulet CFO Wayde McMillan as he takes over the same post. Carrie Cox is the board chair and former NuVasive CEO Christopher Barry is the new President of Medical Solutions.